Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumatriptan for CGRP-Induced Headache
NCT03542357Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Feb 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in migraine comparing Sumatriptan with Placebo (2 arms). Primary endpoint: Area Under the Curve at 1 year. Started Feb 2018; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03542357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03542357.